Chengliang Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chengliang Sun has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Peng Yang
China Pharmaceutical University
2 shared publications Fei Xia
State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, 210009, China; Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, 211198, China
1 shared publicationGefei Wang
State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China
1 shared publicationGuoyu Zhang
State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China
1 shared publicationHaoling Zhang
State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, 210009, China; Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, 211198, China
1 shared publicationHuanaoyu Yang
State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, 210009, China; Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, 211198, China
1 shared publication
Latest Publications
- 1 August 2023
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 259, 115702
Targeting polyketide synthase 13 for the treatment of tuberculosis
- 1 August 2023
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 259, 115702
Targeting polyketide synthase 13 for the treatment of tuberculosis
- Open Access
- 23 May 2023
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 13 (9) , 3583-3597
Bispecific antibodies in cancer therapy: Target selection and regulatory requirements
- 23 May 2023
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 13 (9) , 3583-3597
Open AccessBispecific antibodies in cancer therapy: Target selection and regulatory requirements